domperidone has been researched along with td-5108 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Camilleri, M; Chedid, V; Erwin, PJ; Mandawat, A; Murad, MH; Vijayvargiya, P | 1 |
Fehse, C; Gergs, U; Hofmann, B; Marušáková, M; Neumann, J; Seidler, T | 1 |
1 review(s) available for domperidone and td-5108
Article | Year |
---|---|
Effects of Promotility Agents on Gastric Emptying and Symptoms: A Systematic Review and Meta-analysis.
Topics: Breath Tests; Cisapride; Domperidone; Dopamine D2 Receptor Antagonists; Dyspepsia; Gastric Emptying; Gastroparesis; Ghrelin; Humans; Macrocyclic Compounds; Oligopeptides; Radionuclide Imaging; Randomized Controlled Trials as Topic; Serotonin 5-HT4 Receptor Agonists; Symptom Assessment | 2019 |
1 other study(ies) available for domperidone and td-5108
Article | Year |
---|---|
Cardiovascular effects of metoclopramide and domperidone on human 5-HT
Topics: Aged; Animals; Calcium-Binding Proteins; Cardiovascular Agents; Domperidone; Dopamine Antagonists; Heart; Humans; In Vitro Techniques; Male; Metoclopramide; Mice, Transgenic; Middle Aged; Myocardial Contraction; Myocytes, Cardiac; Phosphorylation; Receptors, Serotonin, 5-HT4; Serotonin 5-HT4 Receptor Agonists; Serotonin 5-HT4 Receptor Antagonists | 2021 |